var data={"title":"Dengue virus infection: Clinical manifestations and diagnosis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Dengue virus infection: Clinical manifestations and diagnosis</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Stephen J Thomas, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Alan L Rothman, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Anon Srikiatkhachorn, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Siripen Kalayanarooj, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Martin S Hirsch, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Elinor L Baron, MD, DTMH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Mar 13, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Dengue is a febrile illness caused by infection with one of four dengue viruses (DENV) transmitted by <em>Aedes aegypti</em> or <em>Aedes</em> <em>albopictus</em> mosquitoes during the taking of a blood meal [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/1-3\" class=\"abstract_t\">1-3</a>]. Infection may be asymptomatic or present with a broad range of clinical manifestations including a mild febrile illness to a life-threatening shock syndrome. Numerous viral, host, and vector factors are thought to impact risk of infection, disease, and disease severity.</p><p>There are four closely related but serologically distinct DENV types of the genus <em>Flavivirus</em>, called DENV-1, DENV-2, DENV-3, and DENV-4. There is transient cross-protection among the four types, which weakens and disappears over the months following infection; therefore, individuals living in a dengue-endemic area with all types co-circulating are at risk for infection with any and all DENV types.</p><p>Issues related to clinical manifestations and diagnosis of DENV infection will be reviewed here. Issues related to epidemiology, pathogenesis, prevention, and treatment are discussed separately. (See <a href=\"topic.htm?path=dengue-virus-infection-pathogenesis\" class=\"medical medical_review\">&quot;Dengue virus infection: Pathogenesis&quot;</a> and <a href=\"topic.htm?path=dengue-virus-infection-prevention-and-treatment\" class=\"medical medical_review\">&quot;Dengue virus infection: Prevention and treatment&quot;</a> and <a href=\"topic.htm?path=dengue-virus-infection-epidemiology\" class=\"medical medical_review\">&quot;Dengue virus infection: Epidemiology&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3997742967\"><span class=\"h1\">CLASSIFICATION SCHEMES</span></p><p class=\"headingAnchor\" id=\"H806351449\"><span class=\"h2\">Overview</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In 1997, the World Health Organization (WHO) published a classification scheme describing three categories of symptomatic dengue virus (DENV) infection: dengue fever (DF), dengue hemorrhagic fever (DHF), and dengue shock syndrome (DSS) [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/4\" class=\"abstract_t\">4</a>]. (See <a href=\"#H3996738437\" class=\"local\">'WHO 1997 classification'</a> below.)</p><p>The WHO 1997 classification scheme is data driven and evidence based but has been criticized [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/5\" class=\"abstract_t\">5</a>]. The term DHF suggests that hemorrhage is the cardinal manifestation of severe dengue; however, plasma leakage leading to intravascular volume depletion and potentially shock is the most specific feature of severe dengue and the focus of clinical management guidelines and algorithms [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/6,7\" class=\"abstract_t\">6,7</a>]. In addition, some patients with severe illness requiring medical intervention do not meet all criteria for DHF. It is generally believed that use of the 1997 WHO definition for DHF underestimates the clinical burden of DENV infection [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/8\" class=\"abstract_t\">8</a>].</p><p>In response to a wide call to reevaluate dengue disease classification, in 2009 the WHO published a revised classification scheme describing the following categories: dengue without warning signs, dengue with warning signs, and severe dengue [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/9\" class=\"abstract_t\">9</a>] (see <a href=\"#H3426361982\" class=\"local\">'WHO 2009 classification'</a> below). This scheme was proposed to emphasize early recognition of warning signs and thus optimize triage and management decisions. It has been adopted for case reporting and clinical management in many but not all countries. The sensitivity and specificity of the categories in the 2009 scheme for guiding clinical management of patients are not known. The 2009 classification has, in turn, been criticized for a lack of clarity in the criteria for severe dengue and for obscuring distinct disease phenotypes within each category [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/10\" class=\"abstract_t\">10</a>].</p><p>Dengue classification schemes support a range of activities from clinical triage and treatment to epidemiologic and vaccine and drug studies. Each guideline has been evaluated by a number of groups, and the 2009 classification has not superseded the 1997 classification for all aspects of dengue virus infection [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/11-15\" class=\"abstract_t\">11-15</a>]. The WHO issued additional documents on dengue management in 2011 and 2012 [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/16,17\" class=\"abstract_t\">16,17</a>].</p><p class=\"headingAnchor\" id=\"H3996738437\"><span class=\"h2\">WHO 1997 classification</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In 1997, the World Health Organization published a classification scheme describing three categories of symptomatic dengue virus infection: dengue fever, dengue hemorrhagic fever, and dengue shock syndrome [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/4\" class=\"abstract_t\">4</a>]. (See <a href=\"#H3997742967\" class=\"local\">'Classification schemes'</a> above.)</p><p class=\"headingAnchor\" id=\"H1647699899\"><span class=\"h3\">Dengue fever</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Dengue fever (also known as &quot;break-bone fever&quot;) is an acute febrile illness defined by the presence of fever and two or more of the following but not meeting the case definition of dengue hemorrhagic fever [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/4\" class=\"abstract_t\">4</a>] (see <a href=\"#H129991018\" class=\"local\">'Dengue hemorrhagic fever'</a> below):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Headache</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Retro-orbital or ocular pain</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Myalgia <span class=\"nowrap\">and/or</span> bone pain</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Arthralgia</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Rash</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hemorrhagic manifestations (eg, positive tourniquet test, petechiae, <span class=\"nowrap\">purpura/ecchymosis,</span> epistaxis, gum bleeding, blood in emesis, urine, or stool, or vaginal bleeding) </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Leukopenia</p><p/><p class=\"headingAnchor\" id=\"H129991018\"><span class=\"h3\">Dengue hemorrhagic fever</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The cardinal feature of dengue hemorrhagic fever is plasma leakage due to increased vascular permeability as evidenced by hemoconcentration (&ge;20 percent rise in hematocrit above baseline), pleural effusion, or ascites [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/4\" class=\"abstract_t\">4</a>]. DHF is also characterized by fever, thrombocytopenia, and hemorrhagic manifestations (all of which may also occur in the setting of DF) [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/4\" class=\"abstract_t\">4</a>]. (See <a href=\"#H1647699899\" class=\"local\">'Dengue fever'</a> above.)</p><p>In the setting of DHF, the presence of intense abdominal pain, persistent vomiting, and marked restlessness or lethargy, especially coinciding with defervescence, should alert the clinician to possible impending dengue shock syndrome [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/18\" class=\"abstract_t\">18</a>]. (See <a href=\"#H2113002363\" class=\"local\">'Dengue shock syndrome'</a> below.)</p><p>The criteria for DHF comprise a narrow definition that does not encompass all patients with clinically severe or complicated dengue infections [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/5,19\" class=\"abstract_t\">5,19</a>]. (See <a href=\"#H3997742967\" class=\"local\">'Classification schemes'</a> above.)</p><p>According to the guidelines, a DHF diagnosis requires all of the following be present:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fever or history of acute fever lasting 2 to 7 days, occasionally biphasic</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hemorrhagic tendencies evidenced by at least one of the following:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>A positive tourniquet test &ndash; The tourniquet test is performed by inflating a blood pressure cuff on the upper arm to a point midway between the systolic and diastolic pressures for 5 minutes. A test is considered positive when 10 or more petechiae per 2.5 cm (1 inch) square are observed. The test may be negative or mildly positive during the phase of profound shock. It usually becomes positive, sometimes strongly positive, if the test is conducted after recovery from shock.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Petechiae, ecchymoses, or purpura</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Bleeding from the mucosa, gastrointestinal tract, injection sites, or other locations</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Hematemesis or melena</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Thrombocytopenia (100,000 cells per mm<sup>3</sup> or less) &ndash; This number represents a direct count using a phase-contrast microscope (normal is 200,000 to 500,000 per mm<sup>3</sup>). In practice, for outpatients, an approximate count from a peripheral blood smear is acceptable. In healthy individuals, 4 to 10 platelets per oil-immersion field (100x; the average of the readings from 10 oil-immersion fields is recommended) indicates an adequate platelet count. An average of 3 platelets per oil-immersion field is considered low (ie, 100,000 per mm<sup>3</sup>).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Evidence of plasma leakage due to increased vascular permeability manifested by at least one of the following:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>A rise in the hematocrit equal to or greater than 20 percent above average for age, sex, and population</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>A drop in the hematocrit following volume-replacement treatment equal to or greater than 20 percent of baseline</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Signs of plasma leakage such as pleural effusion, ascites, and hypoproteinemia</p><p/><p class=\"headingAnchor\" id=\"H2113002363\"><span class=\"h3\">Dengue shock syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Dengue shock syndrome consists of dengue hemorrhagic fever with marked plasma leakage that leads to circulatory collapse (shock) as evidenced by narrowing pulse pressure or hypotension (<a href=\"image.htm?imageKey=ID%2F109848\" class=\"graphic graphic_table graphicRef109848 \">table 1</a>).</p><p>For a diagnosis of DSS, all of the above four criteria for DHF must be present plus evidence of circulatory failure manifested by:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Rapid and weak pulse</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Narrow pulse pressure (20 mmHg [2.7 kPa]) or manifested by:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Hypotension for age &ndash; Hypotension is defined to be a systolic pressure 80 mmHg (10.7 kPa) for those less than 5 years of age or 90 mmHg (12.0 kPa) for those greater than or equal to 5 years of age. Note that narrow pulse pressure is observed early in the course of shock, whereas hypotension is observed later or in patients who experience severe bleeding.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Cold, clammy skin and restlessness</p><p/><p class=\"headingAnchor\" id=\"H3426361982\"><span class=\"h2\">WHO 2009 classification</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In 2009, the World Health Organization introduced a revised classification scheme consisting of the following categories: dengue without warning signs, dengue with warning signs, and severe dengue [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/9\" class=\"abstract_t\">9</a>]. (See <a href=\"#H3997742967\" class=\"local\">'Classification schemes'</a> above.)</p><p class=\"headingAnchor\" id=\"H2802103392\"><span class=\"h3\">Dengue without warning signs</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A presumptive diagnosis of dengue infection may be made in the setting of residence in or travel to an endemic area plus fever and two of the following [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/9\" class=\"abstract_t\">9</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><span class=\"nowrap\">Nausea/vomiting</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Rash</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Headache, eye pain, muscle ache, or joint pain</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Leukopenia</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Positive tourniquet test</p><p/><p>These clinical manifestations are described further above. (See <a href=\"#H1647699899\" class=\"local\">'Dengue fever'</a> above.)</p><p class=\"headingAnchor\" id=\"H3614769352\"><span class=\"h3\">Dengue with warning signs</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Dengue with warning signs of severe infection includes dengue infection as defined above in addition to any of the following [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/9\" class=\"abstract_t\">9</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Abdominal pain or tenderness</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Persistent vomiting</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Clinical fluid accumulation (ascites, pleural effusion)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mucosal bleeding</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lethargy or restlessness</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hepatomegaly &gt;2 cm</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Increase in hematocrit concurrent with rapid decrease in platelet count</p><p/><p>Issues related to plasma leakage are described further above. (See <a href=\"#H129991018\" class=\"local\">'Dengue hemorrhagic fever'</a> above.)</p><p class=\"headingAnchor\" id=\"H3235950633\"><span class=\"h3\">Severe dengue</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Severe dengue infection includes dengue infection with at least one of the following [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/9\" class=\"abstract_t\">9</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Severe plasma leakage leading to:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Shock</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Fluid accumulation with respiratory distress</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Severe bleeding (as evaluated by clinician)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Severe organ involvement:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) &ge;1000 <span class=\"nowrap\">units/L</span></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Impaired consciousness</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Organ failure</p><p/><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>It is estimated that over 390 million dengue virus (DENV) infections occur each year and approximately 96 million are clinically apparent [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/20\" class=\"abstract_t\">20</a>]. Dengue infections have a higher likelihood of being clinically apparent among adults [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/21\" class=\"abstract_t\">21</a>]; among children, most dengue infections are asymptomatic or minimally symptomatic [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/22,23\" class=\"abstract_t\">22,23</a>]. In one study including more than 3400 children in Southeast Asia and Latin America with acute febrile illness, dengue accounted for approximately 10 percent of cases; the incidence of virologically confirmed dengue virus infection in Southeast Asia and Latin America was 4.6 and 2.9 episodes per 100 person-years, respectively, and the incidence of dengue hemorrhagic fever (DHF) was &lt;0.3 episodes per 100 person-years [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/24\" class=\"abstract_t\">24</a>]. Individuals experiencing a second DENV infection with a different type than the first infection have a greater risk of severe disease [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/19\" class=\"abstract_t\">19</a>]. (See <a href=\"#H3235950633\" class=\"local\">'Severe dengue'</a> above.)</p><p>The incubation period of DENV infection ranges from 3 to 14 days; symptoms typically develop between 4 and 7 days after the bite of an infected mosquito [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/25\" class=\"abstract_t\">25</a>].</p><p>Patients with suspected dengue should be assessed carefully and directed to the appropriate care setting. Early recognition of progression to severe disease and patients at increased risk for severe disease is essential, with prompt initiation of more aggressive therapy when necessary. (See <a href=\"topic.htm?path=dengue-virus-infection-prevention-and-treatment\" class=\"medical medical_review\">&quot;Dengue virus infection: Prevention and treatment&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2508477551\"><span class=\"h2\">Phases of infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Dengue virus infection consists of three phases: a febrile phase, a critical phase, and a recovery phase [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/9\" class=\"abstract_t\">9</a>]. These are described further in the sections below.</p><p>Within the WHO 1997 classification scheme, all three phases of infection occur in the setting of DHF and dengue shock syndrome (DSS); dengue fever (DF) includes febrile and convalescent phases but no critical phase [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/9\" class=\"abstract_t\">9</a>]. (See <a href=\"#H3996738437\" class=\"local\">'WHO 1997 classification'</a> above.)</p><p>Within the WHO 2009 classification scheme, all three phases of infection occur in the setting of severe dengue and dengue with warning signs; dengue without warning signs includes febrile and convalescent phases but no critical phase. (See <a href=\"#H3426361982\" class=\"local\">'WHO 2009 classification'</a> above.)</p><p>Issues related to the WHO classification schemes are discussed further above. (See <a href=\"#H3997742967\" class=\"local\">'Classification schemes'</a> above.)</p><p class=\"headingAnchor\" id=\"H2430841706\"><span class=\"h3\">Febrile phase</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The febrile phase of dengue virus infection is characterized by sudden high-grade fever (&ge;38.5&deg;C) accompanied by headache, vomiting, myalgia, arthralgia, and a transient macular rash in some cases [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/25-27\" class=\"abstract_t\">25-27</a>]. Children have high fever but are generally less symptomatic than adults during the febrile phase. The febrile phase lasts for three to seven days, after which most patients recover without complications.</p><p>Headache, eye pain, and joint pain occur in 60 to 70 percent of cases [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/23\" class=\"abstract_t\">23</a>]. Rash occurs in approximately half of cases; it is more common during primary infection than secondary infection and, when present, generally occurs two to five days after the onset of fever [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/23\" class=\"abstract_t\">23</a>]. It is typically macular or maculopapular and may occur over the face, thorax, abdomen, and extremities; it may be associated with pruritus (<a href=\"image.htm?imageKey=ID%2F97534\" class=\"graphic graphic_picture graphicRef97534 \">picture 1</a>). Additional manifestations may include gastrointestinal symptoms (including anorexia, nausea, vomiting, abdominal pain, and diarrhea) and respiratory tract symptoms (cough, sore throat, and nasal congestion).</p><p>Hemorrhagic manifestations may be observed in the febrile phase <span class=\"nowrap\">and/or</span> critical phase (see <a href=\"#H3232255688\" class=\"local\">'Critical phase'</a> below). The range and severity of hemorrhagic manifestations are variable [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/5,7,28\" class=\"abstract_t\">5,7,28</a>]. Major skin <span class=\"nowrap\">and/or</span> mucosal bleeding (gastrointestinal or vaginal) may occur in adults with no obvious precipitating factors and only minor plasma leakage. In children, clinically significant bleeding occurs rarely, usually in association with profound and prolonged shock. Two Cuban studies noted spontaneous petechiae or ecchymoses in approximately half of patients [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/29,30\" class=\"abstract_t\">29,30</a>]. Other less frequent manifestations included hematemesis (15 to 30 percent), menorrhagia (40 percent of women), melena (5 to 10 percent), and epistaxis (10 percent). Comorbid or preexisting medical conditions (such as peptic ulcer disease) may increase the risk for hemorrhage.</p><p>Physical examination may demonstrate conjunctival injection, pharyngeal erythema, lymphadenopathy, and hepatomegaly [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/26\" class=\"abstract_t\">26</a>]. Facial puffiness, petechiae (on the skin <span class=\"nowrap\">and/or</span> palate), and bruising (particularly at venipuncture sites) may be observed [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/31\" class=\"abstract_t\">31</a>]. A tourniquet test should be performed by inflating a blood pressure cuff on the arm to midway between systolic and diastolic blood pressures for five minutes [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/28,32\" class=\"abstract_t\">28,32</a>]. The skin below the cuff is examined for petechiae one to two minutes after deflating the cuff; presence of 10 or more new petechiae in one square inch area is considered a positive test (<a href=\"image.htm?imageKey=ID%2F97567\" class=\"graphic graphic_picture graphicRef97567 \">picture 2</a>).</p><p>A biphasic (&quot;saddleback&quot;) fever curve has been described in approximately 5 percent of cases; in such patients, acute febrile illness remits and then recurs approximately one to two days later; the second febrile phase lasts one to two days [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/27\" class=\"abstract_t\">27</a>].</p><p>Leukopenia and thrombocytopenia (&le;100,000 <span class=\"nowrap\">cells/mm<sup>3</sup>)</span> are common [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/26,27,33-36\" class=\"abstract_t\">26,27,33-36</a>]. Serum aspartate transaminase (AST) levels are frequently elevated; the elevations are usually modest (2 to 5 times the upper limit of normal values), but marked elevations (5 to 15 times the upper limit of normal) occasionally occur [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/27,33\" class=\"abstract_t\">27,33</a>].</p><p>Between days 3 and 7 of the illness, the clinician must watch for signs of vascular leakage. These include persistent vomiting, increasingly severe abdominal pain, tender hepatomegaly, a high or increasing hematocrit level (&ge;20 percent from baseline) concurrent with a rapid decrease in the platelet count, development of pleural effusions <span class=\"nowrap\">and/or</span> ascites, mucosal bleeding, and lethargy or restlessness [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/29,30,37\" class=\"abstract_t\">29,30,37</a>]. (See <a href=\"#H3614769352\" class=\"local\">'Dengue with warning signs'</a> above and <a href=\"#H3232255688\" class=\"local\">'Critical phase'</a> below.)</p><p class=\"headingAnchor\" id=\"H3232255688\"><span class=\"h3\">Critical phase</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Around the time of defervescence (typically days 3 to 7 of infection), a small proportion of patients (typically children and young adults) develop a systemic vascular leak syndrome characterized by plasma leakage, bleeding, shock, and organ impairment [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/33\" class=\"abstract_t\">33</a>]. The critical phase lasts for 24 to 48 hours.</p><p>Initially, adequate circulation may be maintained by physiologic compensation, resulting in pulse pressure narrowing (systolic pressure minus diastolic pressure &le;20 mmHg) (<a href=\"image.htm?imageKey=ID%2F109848\" class=\"graphic graphic_table graphicRef109848 \">table 1</a>); the patient may appear well, and the systolic pressure may be normal or elevated. Nonetheless, urgent, careful resuscitation is needed; once hypotension develops, systolic pressure falls rapidly and irreversible shock may follow despite aggressive attempts at resuscitation [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/4\" class=\"abstract_t\">4</a>]. (See <a href=\"#H2113002363\" class=\"local\">'Dengue shock syndrome'</a> above and <a href=\"#H3235950633\" class=\"local\">'Severe dengue'</a> above and <a href=\"topic.htm?path=dengue-virus-infection-prevention-and-treatment#H7\" class=\"medical medical_review\">&quot;Dengue virus infection: Prevention and treatment&quot;, section on 'Treatment approach'</a>.)</p><p>Hemorrhagic manifestations may be observed in the febrile phase <span class=\"nowrap\">and/or</span> critical phase. (See <a href=\"#H2430841706\" class=\"local\">'Febrile phase'</a> above.)</p><p>Imaging modalities for detection of plasma leakage include ultrasonography (of the chest and abdomen) and chest radiography. In one study including 158 patients with suspected DHF in Thailand, ultrasonography around the time of defervescence was helpful for detection of pleural effusion and peritoneal fluid; right lateral decubitus chest radiography was also useful for detection of pleural effusion [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/38\" class=\"abstract_t\">38</a>]. Plasma leakage was detected by ultrasound as early as three days after onset of fever; pleural effusions were observed more commonly than ascites.</p><p>Moderate-to-severe thrombocytopenia is common during the critical phase; nadir platelet counts &le;20,000 <span class=\"nowrap\">cells/mm<sup>3</sup></span> may be observed, followed by rapid improvement during the recovery phase [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/1\" class=\"abstract_t\">1</a>]. A transient increase in the activated partial-thromboplastin time and decrease in fibrinogen levels are also common.</p><p>Reversion of the critical phase of altered vascular permeability corresponds with rapid improvement in symptoms.</p><p class=\"headingAnchor\" id=\"H2840804725\"><span class=\"h3\">Convalescent phase</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>During the convalescent phase, plasma leakage and hemorrhage resolve, vital signs stabilize, and accumulated fluids are resorbed. An additional rash (a confluent, erythematous eruption with small islands of unaffected skin that is often pruritic) may appear during the convalescent phase (within one to two days of defervescence and lasting one to five days) (<a href=\"image.htm?imageKey=ID%2F97534\" class=\"graphic graphic_picture graphicRef97534 \">picture 1</a>).</p><p>The recovery phase typically lasts two to four days; adults may have profound fatigue for days to weeks after recovery.</p><p class=\"headingAnchor\" id=\"H1088431897\"><span class=\"h2\">Additional manifestations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Additional manifestations of dengue virus infection may include liver failure, central nervous system involvement, myocardial dysfunction, acute kidney injury, and others [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/39-43\" class=\"abstract_t\">39-43</a>].</p><p>Liver failure has been described following resuscitation from profound shock; in many cases, it may be caused by prolonged hypoperfusion or hypoxia rather than a direct viral effect [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/39,42\" class=\"abstract_t\">39,42</a>]. In addition, abdominal pain (occasionally mimicking an acute abdomen) has been described as a clinical manifestation in case series [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/44\" class=\"abstract_t\">44</a>].</p><p>Neurologic manifestations associated with dengue virus infection include encephalopathy and seizures; permanent neurologic sequelae have been described [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/39,40,45-47\" class=\"abstract_t\">39,40,45-47</a>]. In case series, the frequency of these manifestations is approximately 1 percent [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/41\" class=\"abstract_t\">41</a>]. Clinical manifestations include fever, headache, and lethargy; some patients may have no characteristic features of dengue virus infection [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/40\" class=\"abstract_t\">40</a>]. In such cases, the diagnosis has been supported by serologic testing, culture, or detection by polymerase chain reaction in cerebrospinal fluid [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/40\" class=\"abstract_t\">40</a>]. Other neurologic syndromes that have been reported to be potentially associated with dengue virus infection include stroke, acute pure motor weakness, mononeuropathies, polyneuropathies, Guillain-Barr&eacute; syndrome, and transverse myelitis [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/40,41,43,48\" class=\"abstract_t\">40,41,43,48</a>].</p><p>Cardiovascular manifestations (including myocardial impairment, arrhythmias, and, occasionally, fulminant myocarditis) have been described in patients with dengue virus infection [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/49-51\" class=\"abstract_t\">49-51</a>]. One study including 81 patients with dengue virus in Brazil noted elevated levels of troponin or B-type natriuretic peptide in 15 percent of cases [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/50\" class=\"abstract_t\">50</a>]. Another study including 181 children with dengue virus infection noted transient left ventricular systolic and diastolic dysfunction was common and correlated with severity of plasma leakage [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/52\" class=\"abstract_t\">52</a>]. Reports of histologic findings of myocarditis at autopsy have been notable for detection of dengue virus antigens in cardiomyocytes [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/50,53\" class=\"abstract_t\">50,53</a>].</p><p>Acute kidney injury (AKI) has been reported in up to 3 percent of dengue cases [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/54-57\" class=\"abstract_t\">54-57</a>]. Mechanisms of AKI may include shock, rhabdomyolysis, glomerulonephritis, and acute tubular necrosis.</p><p>Retinal vasculitis and hemophagocytic lymphohistiocytosis have been described in association with dengue virus infection [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/58-60\" class=\"abstract_t\">58-60</a>].</p><p>Dengue vaccines may not provide complete protection from dengue disease; immunized individuals may present with attenuated disease. In addition, there is a theoretical possibility that immunization with a poorly immunogenic dengue vaccine could increase the risk of severe dengue infection with subsequent exposure to wild-type virus. Issues related to dengue vaccine are discussed separately. (See <a href=\"topic.htm?path=dengue-virus-infection-prevention-and-treatment#H5\" class=\"medical medical_review\">&quot;Dengue virus infection: Prevention and treatment&quot;, section on 'Vaccination'</a>.)</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h1\">DIAGNOSIS</span></p><p class=\"headingAnchor\" id=\"H244002665\"><span class=\"h2\">Clinical approach</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of dengue virus (DENV) infection should be suspected in febrile individuals with typical clinical manifestations (fever, headache, nausea, vomiting, retro-orbital pain, myalgia, arthralgia, rash, hemorrhagic manifestations, positive tourniquet test, leukopenia) and relevant epidemiologic exposure (residence in or travel within the past two weeks to an area with mosquito-borne transmission of dengue virus infection). (See <a href=\"topic.htm?path=dengue-virus-infection-epidemiology\" class=\"medical medical_review\">&quot;Dengue virus infection: Epidemiology&quot;</a>.)</p><p>A provisional diagnosis of dengue virus infection is usually established clinically. In regions and seasons with a high incidence of dengue virus infection, the positive predictive value of clinical criteria is high, particularly for illnesses meeting all criteria for dengue hemorrhagic fever (DHF) [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/61\" class=\"abstract_t\">61</a>]. (See <a href=\"#H129991018\" class=\"local\">'Dengue hemorrhagic fever'</a> above.)</p><p>Early clinical presentations of dengue, chikungunya, and Zika virus infection may be indistinguishable. If feasible, laboratory diagnostic confirmation is warranted, but often the results are not be available soon enough to guide initial clinical management.</p><p class=\"headingAnchor\" id=\"H20\"><span class=\"h2\">Laboratory testing</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Laboratory diagnosis of dengue virus infection is established directly by detection of viral components in serum or indirectly by serology. The sensitivity of each approach depends on the duration of the patient's illness as well as when in the course of illness the patient presents for evaluation (<a href=\"image.htm?imageKey=ID%2F113221\" class=\"graphic graphic_figure graphicRef113221 \">figure 1</a>). Detection of viral nucleic acid or viral antigen has high specificity but is more labor intensive and costly; serology has lower specificity but is more accessible and less costly.</p><p>During the first week of illness, the diagnosis of dengue virus infection may be established via detection of viral nucleic acid in serum by means of reverse-transcriptase polymerase chain reaction (RT-PCR) assay (typically positive during the first five days of illness) <strong>or</strong> via detection of viral antigen nonstructural protein 1 (NS1; typically positive during the first seven days of illness). In primary infection, the sensitivity of NS1 detection can exceed 90 percent, and antigenemia may persist for several days after resolution of fever; in secondary infection, the sensitivity of NS1 detection is lower (60 to 80 percent) [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/62-64\" class=\"abstract_t\">62-64</a>].</p><p>Immunoglobulin (Ig)M can be detected as early as four days after the onset of illness (<a href=\"image.htm?imageKey=ID%2F113222\" class=\"graphic graphic_figure graphicRef113222 \">figure 2</a>) [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/1\" class=\"abstract_t\">1</a>]. Detection of IgM in a single specimen obtained from a patient with a clinical syndrome consistent with dengue is widely used to establish a presumptive diagnosis. The diagnosis may be confirmed via IgM seroconversion between paired acute and convalescent phase (obtained 10 to 14 days after the acute phase) specimens; a diagnosis of acute dengue virus infection may be established by a fourfold or greater rise in antibody titer. </p><p>The likelihood of IgG detection depends on whether the infection is primary or secondary (<a href=\"image.htm?imageKey=ID%2F113222\" class=\"graphic graphic_figure graphicRef113222 \">figure 2</a>). Primary dengue infection is characterized by a slow and low titer antibody response; IgG is detectable at low titer beginning seven days after onset of illness and increases slowly. Secondary dengue infection is characterized by a rapid rise in antibody titer beginning four days after onset of illness, with broad cross-reactivity.</p><p>Serologic diagnosis may be confounded in the setting of recent infection or vaccination with an antigenically related flavivirus such as yellow fever virus, Japanese encephalitis virus, or Zika virus.</p><p>Dengue virus infection can be established by virus isolation (culture); in general, this is not warranted as a clinical diagnostic tool since results are usually not available in a clinically meaningful time frame.</p><p>Dengue viral proteins can be detected in tissue samples using immunohistochemical staining [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/65\" class=\"abstract_t\">65</a>]. Liver tissues appear to have the high yield; biopsy is rarely indicated in patients with suspected dengue virus infection, so this method is generally used only for postmortem diagnosis.</p><p class=\"headingAnchor\" id=\"H4157314730\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis of dengue virus infection includes:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Other viral hemorrhagic fevers &ndash; Other viruses capable of causing hemorrhagic fever include Ebola virus, Marburg virus, Lassa virus, yellow fever virus, Crimean-Congo hemorrhagic fever, hantavirus (hemorrhagic fever with renal syndrome), and severe fever with thrombocytopenia syndrome virus (SFTSV). These illnesses can all cause severe multiorgan system illness accompanied by hemorrhage. The diseases may be distinguished based on relevant epidemiologic exposure and polymerase chain reaction or serologic testing. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-ebola-virus-disease\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of Ebola virus disease&quot;</a> and <a href=\"topic.htm?path=marburg-virus\" class=\"medical medical_review\">&quot;Marburg virus&quot;</a> and <a href=\"topic.htm?path=yellow-fever\" class=\"medical medical_review\">&quot;Yellow fever&quot;</a> and <a href=\"topic.htm?path=lassa-fever\" class=\"medical medical_review\">&quot;Lassa fever&quot;</a> and <a href=\"topic.htm?path=crimean-congo-hemorrhagic-fever\" class=\"medical medical_review\">&quot;Crimean-Congo hemorrhagic fever&quot;</a> and <a href=\"topic.htm?path=renal-involvement-with-hantavirus-infection-hemorrhagic-fever-with-renal-syndrome\" class=\"medical medical_review\">&quot;Renal involvement with hantavirus infection (hemorrhagic fever with renal syndrome)&quot;</a> and <a href=\"topic.htm?path=severe-fever-with-thrombocytopenia-syndrome-virus\" class=\"medical medical_review\">&quot;Severe fever with thrombocytopenia syndrome virus&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Chikungunya &ndash; Chikungunya virus and dengue virus cause similar symptoms and signs and are transmitted by the same mosquito vector (<a href=\"image.htm?imageKey=ID%2F106512\" class=\"graphic graphic_table graphicRef106512 \">table 2</a>). In studies comparing the two diseases, joint pain was reported somewhat more often by patients with chikungunya, whereas abdominal pain and leukopenia were more common in those with dengue [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/66-68\" class=\"abstract_t\">66-68</a>]. Joint swelling is highly specific for chikungunya; bleeding manifestations and thrombocytopenia are relatively specific for dengue. The diagnosis of chikungunya virus infection is established via serology or reverse-transcriptase polymerase chain reaction (RT-PCR). (See <a href=\"topic.htm?path=chikungunya-fever\" class=\"medical medical_review\">&quot;Chikungunya fever&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Zika virus infection &ndash; Dengue virus and Zika virus infections have similar clinical manifestations and are transmitted by the same mosquito vector. Unlike dengue virus infection, Zika is commonly associated with conjunctivitis (<a href=\"image.htm?imageKey=ID%2F106512\" class=\"graphic graphic_table graphicRef106512 \">table 2</a>). Coinfection with Zika, chikungunya, and dengue viruses has been described [<a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/69,70\" class=\"abstract_t\">69,70</a>]. The diagnosis of Zika virus infection is established via serology or RT-PCR. (See <a href=\"topic.htm?path=zika-virus-infection-an-overview\" class=\"medical medical_review\">&quot;Zika virus infection: An overview&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Malaria &ndash; Malaria is characterized by fever, malaise, nausea, vomiting, abdominal pain, diarrhea, myalgia, and anemia. The diagnosis of malaria is established by visualization of parasites on peripheral smear. (See <a href=\"topic.htm?path=clinical-manifestations-of-malaria-in-nonpregnant-adults-and-children\" class=\"medical medical_review\">&quot;Clinical manifestations of malaria in nonpregnant adults and children&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Typhoid fever &ndash; Clinical manifestations of typhoid fever include fever, bradycardia, abdominal pain, and rash. The diagnosis is established by stool <span class=\"nowrap\">and/or</span> blood culture. (See <a href=\"topic.htm?path=epidemiology-microbiology-clinical-manifestations-and-diagnosis-of-enteric-typhoid-and-paratyphoid-fever\" class=\"medical medical_review\">&quot;Epidemiology, microbiology, clinical manifestations, and diagnosis of enteric (typhoid and paratyphoid) fever&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Leptospirosis &ndash; Leptospirosis is characterized by fever, rigors, myalgia, conjunctival suffusion, and headache. Less common symptoms and signs include cough, nausea, vomiting, diarrhea, abdominal pain, and arthralgia. The diagnosis is established via serology. (See <a href=\"topic.htm?path=epidemiology-microbiology-clinical-manifestations-and-diagnosis-of-leptospirosis\" class=\"medical medical_review\">&quot;Epidemiology, microbiology, clinical manifestations, and diagnosis of leptospirosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Viral hepatitis &ndash; Causes of viral hepatitis include hepatitis A, B, C, D, and E. Hepatitis A and E are acute infections transmitted by the fecal-oral route, whereas hepatitis B, C, and D can present acutely or chronically and are transmitted by body fluids. They are distinguished via serology (see related topics).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Rickettsial infection &ndash; Rickettsial infections with similar manifestations as dengue virus infection include African tick bite fever and relapsing fever. African tick bite fever is observed among travelers to Africa and the Caribbean and is characterized by headache, fever, myalgia, solitary or multiple eschars with regional lymphadenopathy, and generalized rash; the diagnosis is established via serology. Relapsing fever is characterized by fever, headache, neck stiffness, arthralgia, myalgia, and nausea; diagnostic tools include direct smear and polymerase chain reaction. (See <a href=\"topic.htm?path=other-spotted-fever-group-rickettsial-infections\" class=\"medical medical_review\">&quot;Other spotted fever group rickettsial infections&quot;</a> and <a href=\"topic.htm?path=clinical-features-diagnosis-and-management-of-relapsing-fever\" class=\"medical medical_review\">&quot;Clinical features, diagnosis, and management of relapsing fever&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Sepsis due to bacteremia &ndash; Sepsis due to bacteremia may present with fever, tachycardia, and altered mental status; diagnosis requires blood culture.</p><p/><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &quot;The Basics&quot; and &quot;Beyond the Basics.&quot; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &quot;patient info&quot; and the keyword(s) of interest.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basics topic (see <a href=\"topic.htm?path=dengue-fever-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Dengue fever (The Basics)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H24\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The clinical manifestations of dengue range from self-limited dengue fever to dengue hemorrhagic fever with shock syndrome, which may carry a significant mortality rate if improperly managed. The risk of severe disease is much higher in secondary rather than primary dengue infection. There is also an increasing recognition of atypical syndromes associated with acute dengue virus (DENV) infection, some of which can be severe. (See <a href=\"#H3\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Classic dengue fever is an acute febrile illness accompanied by headache, retro-orbital pain, and marked muscle and bone pains. Fever typically lasts for five to seven days. Hemorrhagic manifestations and thrombocytopenia can also occur. Physical examination is nonspecific but may include a macular or maculopapular rash in approximately half of cases. (See <a href=\"#H1647699899\" class=\"local\">'Dengue fever'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Dengue hemorrhagic fever is the most serious manifestation of DENV infection and can be associated with shock. The four cardinal features of dengue hemorrhagic fever include increased vascular permeability, fever, hemorrhagic manifestations, and marked thrombocytopenia (100,000 <span class=\"nowrap\">cells/mm<sup>3</sup></span> or lower). (See <a href=\"#H129991018\" class=\"local\">'Dengue hemorrhagic fever'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Plasma leakage is the most specific and life-threatening feature of dengue hemorrhagic fever and usually occurs over a period of 24 to 48 hours, typically coincident with defervescence. Severe plasma leakage can occur in patients with minimal hemorrhagic manifestations. (See <a href=\"#H129991018\" class=\"local\">'Dengue hemorrhagic fever'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hemorrhagic manifestations of DENV infection can range from spontaneous petechiae to profuse bleeding. Severe bleeding sometimes occurs in the absence of plasma leakage. (See <a href=\"#H1647699899\" class=\"local\">'Dengue fever'</a> above and <a href=\"#H129991018\" class=\"local\">'Dengue hemorrhagic fever'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of acute DENV infection is based mainly on clinical signs and symptoms in patients exposed to dengue by residence in or travel to a dengue-endemic country or region. In settings where serologic assays are available, we favor use of an acute-phase serum sample for use in an immunoglobulin (Ig)M immunoassay (IgM antibody capture enzyme-linked immunosorbent assay [MAC-ELISA] or equivalent) as the laboratory test of choice. If the IgM immunoassay is negative and the serum was obtained within the first six days after onset of illness, we favor testing the sample for dengue viral nonstructural protein 1 (NS1) antigen by enzyme-linked immunosorbent assay (ELISA). (See <a href=\"#H18\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>If the clinical suspicion of DENV infection is high and the assay results on the acute-phase sample are negative, we favor testing paired acute and convalescent sera for antibodies to dengue virus by hemagglutination inhibition assay or IgG ELISA. If other diagnoses are being entertained, testing should be considered. (See <a href=\"#H18\" class=\"local\">'Diagnosis'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/1\" class=\"nounderline abstract_t\">Simmons CP, Farrar JJ, Nguyen vV, Wills B. Dengue. N Engl J Med 2012; 366:1423.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/2\" class=\"nounderline abstract_t\">Guzman MG, Harris E. Dengue. Lancet 2015; 385:453.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/3\" class=\"nounderline abstract_t\">Kularatne SA. Dengue fever. BMJ 2015; 351:h4661.</a></li><li class=\"breakAll\">World Health Organization. Dengue haemorrhagic fever: Diagnosis, treatment, prevention and control, 2nd edition. WHO, Geneva 1997. http://apps.who.int/iris/bitstream/10665/41988/1/9241545003_eng.pdf (Accessed on December 07, 2016).</li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/5\" class=\"nounderline abstract_t\">Phuong CX, Nhan NT, Kneen R, et al. Clinical diagnosis and assessment of severity of confirmed dengue infections in Vietnamese children: is the world health organization classification system helpful? Am J Trop Med Hyg 2004; 70:172.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/6\" class=\"nounderline abstract_t\">Wichmann O, Gascon J, Schunk M, et al. Severe dengue virus infection in travelers: risk factors and laboratory indicators. J Infect Dis 2007; 195:1089.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/7\" class=\"nounderline abstract_t\">Srikiatkhachorn A, Gibbons RV, Green S, et al. Dengue hemorrhagic fever: the sensitivity and specificity of the world health organization definition for identification of severe cases of dengue in Thailand, 1994-2005. Clin Infect Dis 2010; 50:1135.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/8\" class=\"nounderline abstract_t\">Anderson KB, Chunsuttiwat S, Nisalak A, et al. Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study. Lancet 2007; 369:1452.</a></li><li class=\"breakAll\">World Health Organization. Dengue: Guidelines for diagnosis, treatment, prevention and control, New edition. WHO: Geneva 2009. http://www.who.int/tdr/publications/documents/dengue-diagnosis.pdf?ua=1 (Accessed on December 07, 2016).</li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/10\" class=\"nounderline abstract_t\">Srikiatkhachorn A, Rothman AL, Gibbons RV, et al. Dengue--how best to classify it. Clin Infect Dis 2011; 53:563.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/11\" class=\"nounderline abstract_t\">Zakaria Z, Zainordin NA, Sim BL, et al. An evaluation of the World Health Organization's 1997 and 2009 dengue classifications in hospitalized dengue patients in Malaysia. J Infect Dev Ctries 2014; 8:869.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/12\" class=\"nounderline abstract_t\">Horstick O, Jaenisch T, Martinez E, et al. Comparing the usefulness of the 1997 and 2009 WHO dengue case classification: a systematic literature review. Am J Trop Med Hyg 2014; 91:621.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/13\" class=\"nounderline abstract_t\">Nujum ZT, Thomas A, Vijayakumar K, et al. Comparative performance of the probable case definitions of dengue by WHO (2009) and the WHO-SEAR expert group (2011). Pathog Glob Health 2014; 108:103.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/14\" class=\"nounderline abstract_t\">Gan VC, Lye DC, Thein TL, et al. Implications of discordance in world health organization 1997 and 2009 dengue classifications in adult dengue. PLoS One 2013; 8:e60946.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/15\" class=\"nounderline abstract_t\">Wieten RW, Vlietstra W, Goorhuis A, et al. Dengue in travellers: applicability of the 1975-1997 and the 2009 WHO classification system of dengue fever. Trop Med Int Health 2012; 17:1023.</a></li><li class=\"breakAll\">World Health Organization Regional Office for Southeast Asia. Comprehensive guidelines for prevention and control of dengue and dengue haemorrhagic fever. Revised and expanded version. SEARO Technical Publication Series, New Delhi, India 2011.</li><li class=\"breakAll\">World Health Organization. Handbook for clinical management of dengue. WHO, Geneva 2012. http://www.wpro.who.int/mvp/documents/handbook_for_clinical_management_of_dengue.pdf (Accessed on September 13, 2016).</li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/18\" class=\"nounderline abstract_t\">Rigau-P&eacute;rez JG, Laufer MK. Dengue-related deaths in Puerto Rico, 1992-1996: diagnosis and clinical alarm signals. Clin Infect Dis 2006; 42:1241.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/19\" class=\"nounderline abstract_t\">Deen JL, Harris E, Wills B, et al. The WHO dengue classification and case definitions: time for a reassessment. Lancet 2006; 368:170.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/20\" class=\"nounderline abstract_t\">Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue. Nature 2013; 496:504.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/21\" class=\"nounderline abstract_t\">SABIN AB. Research on dengue during World War II. Am J Trop Med Hyg 1952; 1:30.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/22\" class=\"nounderline abstract_t\">Endy TP, Chunsuttiwat S, Nisalak A, et al. Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol 2002; 156:40.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/23\" class=\"nounderline abstract_t\">Cobra C, Rigau-P&eacute;rez JG, Kuno G, Vorndam V. Symptoms of dengue fever in relation to host immunologic response and virus serotype, Puerto Rico, 1990-1991. Am J Epidemiol 1995; 142:1204.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/24\" class=\"nounderline abstract_t\">L'Azou M, Moureau A, Sarti E, et al. Symptomatic Dengue in Children in 10 Asian and Latin American Countries. N Engl J Med 2016; 374:1155.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/25\" class=\"nounderline abstract_t\">Fukusumi M, Arashiro T, Arima Y, et al. Dengue Sentinel Traveler Surveillance: Monthly and Yearly Notification Trends among Japanese Travelers, 2006-2014. PLoS Negl Trop Dis 2016; 10:e0004924.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/26\" class=\"nounderline abstract_t\">Trofa AF, DeFraites RF, Smoak BL, et al. Dengue fever in US military personnel in Haiti. JAMA 1997; 277:1546.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/27\" class=\"nounderline abstract_t\">Leder K, Torresi J, Brownstein JS, et al. Travel-associated illness trends and clusters, 2000-2010. Emerg Infect Dis 2013; 19:1049.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/28\" class=\"nounderline abstract_t\">Cao XT, Ngo TN, Wills B, et al. Evaluation of the World Health Organization standard tourniquet test and a modified tourniquet test in the diagnosis of dengue infection in Viet Nam. Trop Med Int Health 2002; 7:125.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/29\" class=\"nounderline abstract_t\">D&iacute;az A, Kour&iacute; G, Guzm&aacute;n MG, et al. Description of the clinical picture of dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) in adults. Bull Pan Am Health Organ 1988; 22:133.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/30\" class=\"nounderline abstract_t\">Guzm&aacute;n MG, Kour&iacute; G, Mart&iacute;nez E, et al. Clinical and serologic study of Cuban children with dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS). Bull Pan Am Health Organ 1987; 21:270.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/31\" class=\"nounderline abstract_t\">Cunha BA, Apostolopoulou A, Sivarajah T, Klein NC. Facial Puffiness in a Returning Traveler From Puerto Rico: Chikungunya, Dengue Fever, or Zika Virus? Clin Infect Dis 2016; 63:1264.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/32\" class=\"nounderline abstract_t\">Wilder-Smith A, Schwartz E. Dengue in travelers. N Engl J Med 2005; 353:924.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/33\" class=\"nounderline abstract_t\">Kalayanarooj S, Vaughn DW, Nimmannitya S, et al. Early clinical and laboratory indicators of acute dengue illness. J Infect Dis 1997; 176:313.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/34\" class=\"nounderline abstract_t\">Potts JA, Rothman AL. Clinical and laboratory features that distinguish dengue from other febrile illnesses in endemic populations. Trop Med Int Health 2008; 13:1328.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/35\" class=\"nounderline abstract_t\">Halstead SB. Dengue. Lancet 2007; 370:1644.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/36\" class=\"nounderline abstract_t\">Tanner L, Schreiber M, Low JG, et al. Decision tree algorithms predict the diagnosis and outcome of dengue fever in the early phase of illness. PLoS Negl Trop Dis 2008; 2:e196.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/37\" class=\"nounderline abstract_t\">Khor BS, Liu JW, Lee IK, Yang KD. Dengue hemorrhagic fever patients with acute abdomen: clinical experience of 14 cases. Am J Trop Med Hyg 2006; 74:901.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/38\" class=\"nounderline abstract_t\">Srikiatkhachorn A, Krautrachue A, Ratanaprakarn W, et al. Natural history of plasma leakage in dengue hemorrhagic fever: a serial ultrasonographic study. Pediatr Infect Dis J 2007; 26:283.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/39\" class=\"nounderline abstract_t\">Chhour YM, Ruble G, Hong R, et al. Hospital-based diagnosis of hemorrhagic fever, encephalitis, and hepatitis in Cambodian children. Emerg Infect Dis 2002; 8:485.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/40\" class=\"nounderline abstract_t\">Solomon T, Dung NM, Vaughn DW, et al. Neurological manifestations of dengue infection. Lancet 2000; 355:1053.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/41\" class=\"nounderline abstract_t\">Carod-Artal FJ, Wichmann O, Farrar J, Gasc&oacute;n J. Neurological complications of dengue virus infection. Lancet Neurol 2013; 12:906.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/42\" class=\"nounderline abstract_t\">Neeraja M, Iakshmi V, Teja VD, et al. Unusual and rare manifestations of dengue during a dengue outbreak in a tertiary care hospital in South India. Arch Virol 2014; 159:1567.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/43\" class=\"nounderline abstract_t\">Verma R, Sahu R, Holla V. Neurological manifestations of dengue infection: a review. J Neurol Sci 2014; 346:26.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/44\" class=\"nounderline abstract_t\">Pires Neto Rda J, de S&aacute; SL, Pinho SC, et al. Dengue infection in children and adolescents: clinical profile in a reference hospital in northeast Brazil. Rev Soc Bras Med Trop 2013; 46:765.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/45\" class=\"nounderline abstract_t\">Misra UK, Kalita J, Syam UK, Dhole TN. Neurological manifestations of dengue virus infection. J Neurol Sci 2006; 244:117.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/46\" class=\"nounderline abstract_t\">Ara&uacute;jo FM, Ara&uacute;jo MS, Nogueira RM, et al. Central nervous system involvement in dengue: a study in fatal cases from a dengue endemic area. Neurology 2012; 78:736.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/47\" class=\"nounderline abstract_t\">Sahu R, Verma R, Jain A, et al. Neurologic complications in dengue virus infection: a prospective cohort study. Neurology 2014; 83:1601.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/48\" class=\"nounderline abstract_t\">Li HM, Huang YK, Su YC, Kao CH. Risk of stroke in patients with dengue fever: a population-based cohort study. CMAJ 2018; 190:E285.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/49\" class=\"nounderline abstract_t\">Yacoub S, Griffiths A, Chau TT, et al. Cardiac function in Vietnamese patients with different dengue severity grades. Crit Care Med 2012; 40:477.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/50\" class=\"nounderline abstract_t\">Miranda CH, Borges Mde C, Matsuno AK, et al. Evaluation of cardiac involvement during dengue viral infection. Clin Infect Dis 2013; 57:812.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/51\" class=\"nounderline abstract_t\">Yacoub S, Wertheim H, Simmons CP, et al. Cardiovascular manifestations of the emerging dengue pandemic. Nat Rev Cardiol 2014; 11:335.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/52\" class=\"nounderline abstract_t\">Kirawittaya T, Yoon IK, Wichit S, et al. Evaluation of Cardiac Involvement in Children with Dengue by Serial Echocardiographic Studies. PLoS Negl Trop Dis 2015; 9:e0003943.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/53\" class=\"nounderline abstract_t\">Salgado DM, Eltit JM, Mansfield K, et al. Heart and skeletal muscle are targets of dengue virus infection. Pediatr Infect Dis J 2010; 29:238.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/54\" class=\"nounderline abstract_t\">Lee IK, Liu JW, Yang KD. Clinical characteristics, risk factors, and outcomes in adults experiencing dengue hemorrhagic fever complicated with acute renal failure. Am J Trop Med Hyg 2009; 80:651.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/55\" class=\"nounderline abstract_t\">Laoprasopwattana K, Pruekprasert P, Dissaneewate P, et al. Outcome of dengue hemorrhagic fever-caused acute kidney injury in Thai children. J Pediatr 2010; 157:303.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/56\" class=\"nounderline abstract_t\">Basu G, Chrispal A, Boorugu H, et al. Acute kidney injury in tropical acute febrile illness in a tertiary care centre--RIFLE criteria validation. Nephrol Dial Transplant 2011; 26:524.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/57\" class=\"nounderline abstract_t\">Huang SY, Lee IK, Liu JW, et al. Clinical features of and risk factors for rhabdomyolysis among adult patients with dengue virus infection. Am J Trop Med Hyg 2015; 92:75.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/58\" class=\"nounderline abstract_t\">Chan DP, Teoh SC, Tan CS, et al. Ophthalmic complications of dengue. Emerg Infect Dis 2006; 12:285.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/59\" class=\"nounderline abstract_t\">Tan LH, Lum LC, Omar SF, Kan FK. Hemophagocytosis in dengue: comprehensive report of six cases. J Clin Virol 2012; 55:79.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/60\" class=\"nounderline abstract_t\">Sharp TM, Gaul L, Muehlenbachs A, et al. Fatal hemophagocytic lymphohistiocytosis associated with locally acquired dengue virus infection - New Mexico and Texas, 2012. MMWR Morb Mortal Wkly Rep 2014; 63:49.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/61\" class=\"nounderline abstract_t\">Kalayanarooj S, Chansiriwongs V, Nimmannitya S. Dengue patients at the Children&rsquo;s Hospital, Bangkok: 1995-1999 review. Dengue Bulletin 2002; 26:33.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/62\" class=\"nounderline abstract_t\">Guzman MG, Jaenisch T, Gaczkowski R, et al. Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosis. PLoS Negl Trop Dis 2010; 4.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/63\" class=\"nounderline abstract_t\">Hunsperger EA, Mu&ntilde;oz-Jord&aacute;n J, Beltran M, et al. Performance of Dengue Diagnostic Tests in a Single-Specimen Diagnostic Algorithm. J Infect Dis 2016; 214:836.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/64\" class=\"nounderline abstract_t\">Huits R, Soentjens P, Maniewski-Kelner U, et al. Clinical Utility of the Nonstructural 1 Antigen Rapid Diagnostic Test in the Management of Dengue in Returning Travelers With Fever. Open Forum Infect Dis 2017; 4:ofw273.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/65\" class=\"nounderline abstract_t\">Jessie K, Fong MY, Devi S, et al. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis 2004; 189:1411.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/66\" class=\"nounderline abstract_t\">Taraphdar D, Sarkar A, Mukhopadhyay BB, Chatterjee S. A comparative study of clinical features between monotypic and dual infection cases with Chikungunya virus and dengue virus in West Bengal, India. Am J Trop Med Hyg 2012; 86:720.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/67\" class=\"nounderline abstract_t\">Lee VJ, Chow A, Zheng X, et al. Simple clinical and laboratory predictors of Chikungunya versus dengue infections in adults. PLoS Negl Trop Dis 2012; 6:e1786.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/68\" class=\"nounderline abstract_t\">Mohd Zim MA, Sam IC, Omar SF, et al. Chikungunya infection in Malaysia: comparison with dengue infection in adults and predictors of persistent arthralgia. J Clin Virol 2013; 56:141.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/69\" class=\"nounderline abstract_t\">Villamil-G&oacute;mez WE, Gonz&aacute;lez-Camargo O, Rodriguez-Ayubi J, et al. Dengue, chikungunya and Zika co-infection in a patient from Colombia. J Infect Public Health 2016; 9:684.</a></li><li><a href=\"https://www.uptodate.com/contents/dengue-virus-infection-clinical-manifestations-and-diagnosis/abstract/70\" class=\"nounderline abstract_t\">Waggoner JJ, Gresh L, Vargas MJ, et al. Viremia and Clinical Presentation in Nicaraguan Patients Infected With Zika Virus, Chikungunya Virus, and Dengue Virus. Clin Infect Dis 2016; 63:1584.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 3025 Version 34.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H24\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H3997742967\" id=\"outline-link-H3997742967\">CLASSIFICATION SCHEMES</a><ul><li><a href=\"#H806351449\" id=\"outline-link-H806351449\">Overview</a></li><li><a href=\"#H3996738437\" id=\"outline-link-H3996738437\">WHO 1997 classification</a><ul><li><a href=\"#H1647699899\" id=\"outline-link-H1647699899\">- Dengue fever</a></li><li><a href=\"#H129991018\" id=\"outline-link-H129991018\">- Dengue hemorrhagic fever</a></li><li><a href=\"#H2113002363\" id=\"outline-link-H2113002363\">- Dengue shock syndrome</a></li></ul></li><li><a href=\"#H3426361982\" id=\"outline-link-H3426361982\">WHO 2009 classification</a><ul><li><a href=\"#H2802103392\" id=\"outline-link-H2802103392\">- Dengue without warning signs</a></li><li><a href=\"#H3614769352\" id=\"outline-link-H3614769352\">- Dengue with warning signs</a></li><li><a href=\"#H3235950633\" id=\"outline-link-H3235950633\">- Severe dengue</a></li></ul></li></ul></li><li><a href=\"#H3\" id=\"outline-link-H3\">CLINICAL MANIFESTATIONS</a><ul><li><a href=\"#H2508477551\" id=\"outline-link-H2508477551\">Phases of infection</a><ul><li><a href=\"#H2430841706\" id=\"outline-link-H2430841706\">- Febrile phase</a></li><li><a href=\"#H3232255688\" id=\"outline-link-H3232255688\">- Critical phase</a></li><li><a href=\"#H2840804725\" id=\"outline-link-H2840804725\">- Convalescent phase</a></li></ul></li><li><a href=\"#H1088431897\" id=\"outline-link-H1088431897\">Additional manifestations</a></li></ul></li><li><a href=\"#H18\" id=\"outline-link-H18\">DIAGNOSIS</a><ul><li><a href=\"#H244002665\" id=\"outline-link-H244002665\">Clinical approach</a></li><li><a href=\"#H20\" id=\"outline-link-H20\">Laboratory testing</a></li></ul></li><li><a href=\"#H4157314730\" id=\"outline-link-H4157314730\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H99088459\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H24\" id=\"outline-link-H24\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/3025|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=ID/113221\" class=\"graphic graphic_figure\">- Dengue diagnostic tests</a></li><li><a href=\"image.htm?imageKey=ID/113222\" class=\"graphic graphic_figure\">- Dengue antibody kinetics</a></li></ul></li><li><div id=\"ID/3025|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=ID/97534\" class=\"graphic graphic_picture\">- Dengue rash</a></li><li><a href=\"image.htm?imageKey=ID/97567\" class=\"graphic graphic_picture\">- Tourniquet test</a></li></ul></li><li><div id=\"ID/3025|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ID/109848\" class=\"graphic graphic_table\">- Dengue hemodynamic assessment</a></li><li><a href=\"image.htm?imageKey=ID/106512\" class=\"graphic graphic_table\">- Zika vs dengue vs chikungunya</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=chikungunya-fever\" class=\"medical medical_review\">Chikungunya fever</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-diagnosis-and-management-of-relapsing-fever\" class=\"medical medical_review\">Clinical features, diagnosis, and management of relapsing fever</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-ebola-virus-disease\" class=\"medical medical_review\">Clinical manifestations and diagnosis of Ebola virus disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-of-malaria-in-nonpregnant-adults-and-children\" class=\"medical medical_review\">Clinical manifestations of malaria in nonpregnant adults and children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=crimean-congo-hemorrhagic-fever\" class=\"medical medical_review\">Crimean-Congo hemorrhagic fever</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=dengue-virus-infection-epidemiology\" class=\"medical medical_review\">Dengue virus infection: Epidemiology</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=dengue-virus-infection-pathogenesis\" class=\"medical medical_review\">Dengue virus infection: Pathogenesis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=dengue-virus-infection-prevention-and-treatment\" class=\"medical medical_review\">Dengue virus infection: Prevention and treatment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-microbiology-clinical-manifestations-and-diagnosis-of-enteric-typhoid-and-paratyphoid-fever\" class=\"medical medical_review\">Epidemiology, microbiology, clinical manifestations, and diagnosis of enteric (typhoid and paratyphoid) fever</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-microbiology-clinical-manifestations-and-diagnosis-of-leptospirosis\" class=\"medical medical_review\">Epidemiology, microbiology, clinical manifestations, and diagnosis of leptospirosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=lassa-fever\" class=\"medical medical_review\">Lassa fever</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=marburg-virus\" class=\"medical medical_review\">Marburg virus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=other-spotted-fever-group-rickettsial-infections\" class=\"medical medical_review\">Other spotted fever group rickettsial infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=dengue-fever-the-basics\" class=\"medical medical_basics\">Patient education: Dengue fever (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=renal-involvement-with-hantavirus-infection-hemorrhagic-fever-with-renal-syndrome\" class=\"medical medical_review\">Renal involvement with hantavirus infection (hemorrhagic fever with renal syndrome)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=severe-fever-with-thrombocytopenia-syndrome-virus\" class=\"medical medical_review\">Severe fever with thrombocytopenia syndrome virus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=yellow-fever\" class=\"medical medical_review\">Yellow fever</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=zika-virus-infection-an-overview\" class=\"medical medical_review\">Zika virus infection: An overview</a></li></ul></div></div>","javascript":null}